Delivery Order SPE2DB22D1106-SPE2DB24FEGC1
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $18K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,447,476 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has a potential value of $13,504.82 and a performance period through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which was not set aside for any particular business type....
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MULTAQ 400 MG TABLET 60S. The $2,064.31 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any subcontractors. The contract was awarded on February 9, 2024 and does not have a set-aside...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $19,061.10 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,449,026 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $9,835.70 contract is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to be completed by February 15, 2024. This order is placed under Amerisourcebergen's existing $999,999,999.00 indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,558,085,095 MULTAQ 400 MG TABLET 60S. The $111,931.36 contract has an August 15, 2022 completion date and was awarded on August 12, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MULTAQ 400 MG TABLET 60S. The $4,312.36 contract has a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts to provide pharmaceuticals, medical supplies, and distribution services to DLA programs. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $42,929.06 contract is for the supply of the prescription medication MULTAQ 400 MG TABLET 60S. The delivery order has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,579.37 award is for the supply of MULTAQ 400 MG TABLET 60S pharmaceuticals, with a completion date of January 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has an ongoing relationship with DLA Troop Support Medical, providing a range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,584.20 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,440,564 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,793.26 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of MULTAQ 400 MG TABLET 60S. This contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEGC1Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MULTAQ 400 MG TABLET 60S pharmaceuticals. The $17,601.39 contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide. This latest delivery order was not set aside for any specific business type.
Generated 6/19/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 3/20/24 |